NewGenIvf Group Limited (NIVFW) 주식 분석

회사 개요

NewGenIvf Group Limited operates as an investment holding company focused on assisted reproductive services, facilitating fertility treatments for couples and individuals across Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company offers a comprehensive suite of fertility treatment solutions, specifically including in vitro fertilization procedures within these international markets. Although the specific sector and industry classifications are not disclosed in the available data, the business model relies on specialized medical services in the reproductive health domain. The company's market capitalization is not currently listed, and its annual revenue for the trailing twelve months stands at $4.73 million, with no employee count provided. These financial figures suggest the entity functions as a specialized operator within a niche medical tourism or cross-border healthcare landscape, where the lack of a disclosed market cap indicates either a micro-cap status or a specific reporting structure that warrants close examination of its underlying operational metrics.

재무 건전성

The company reported a revenue of $4.73 million over the trailing twelve months, while simultaneously generating a net income of $9.88 million, creating a significant divergence between top-line earnings and bottom-line profitability. This unusual gap where net income exceeds revenue by more than double implies an accounting structure involving substantial non-operating income, tax benefits, or adjustments that are not immediately reflected in the gross revenue stream. Despite the positive net income, the EBITDA stands at a negative $10,538,352, indicating that the core operating cash generation before interest and taxes is currently insufficient to cover operational costs without external financing or non-operating support. Free cash flow is reported at a negative $11,179,275, which signals that the company is burning cash and lacks the internal liquidity to fund expansion or operations without relying on capital markets or debt issuance. The gross margin is calculated at 20.2%, reflecting the proportion of revenue remaining after direct costs of services are deducted, while the operating margin is deeply negative at -349.1%, highlighting severe inefficiencies or high fixed cost burdens relative to operating revenue. Conversely, the profit margin is reported at 209.0%, a metric that is mathematically possible only when non-operating income significantly outweighs operating losses, suggesting a highly leveraged or asset-heavy accounting reality. On the liquidity front, the company holds $1.30 million in cash against $4.87 million in total debt, resulting in a debt-to-equity ratio of 18.74, which indicates a highly leveraged balance sheet where equity is minimal relative to obligations. The current ratio of 3.12 suggests that current assets are more than three times current liabilities, pointing to strong short-term liquidity despite the high leverage and negative operating cash flows. Return on equity is an exceptionally high 79.4%, while return on assets is negative at -36.9%, revealing that management is generating substantial returns on shareholder equity through financial engineering or non-operating gains, but the asset base is currently destroying value rather than creating it.

밸류에이션 평가

The trailing P/E ratio and forward P/E ratio are not available due to the lack of positive earnings per share data in standard valuation metrics or the specific reporting conditions of the company. The price-to-book ratio is listed at 0.00, which indicates that the market capitalization is effectively zero or negligible relative to the company's book value, suggesting the market does not assign a premium to the underlying equity assets. The price-to-sales ratio and EV/EBITDA are also not disclosed in the available facts, meaning alternative valuation metrics cannot be utilized to assess the company's intrinsic value or relative standing against peers. The stock's 52-week high is $0.02 and the 52-week low is $0.02, indicating that the share price has been stagnant within this narrow range throughout the year. Because the high and low are identical, the current trading price sits exactly at the midpoint of this static range, reflecting a lack of price momentum or significant trading interest. The beta value is not available, preventing an assessment of the stock's volatility relative to the broader market index. These valuation data points collectively present a picture of a stock with no clear valuation multiples, limited price movement, and a price-to-book structure that suggests extreme caution regarding the equity's market value.

Growth & Income

Revenue growth for the year-over-year period is recorded at 11.9%, demonstrating a positive expansion in top-line sales, whereas earnings growth is not available due to the specific nature of the reported net income figures. The divergence between the positive revenue growth and the unavailable or anomalous earnings growth suggests that profitability dynamics are decoupled from revenue expansion, likely driven by the non-operating income factors mentioned in the financial health section. The company does not pay dividends, as indicated by the missing dividend yield and payout ratio data, which implies that the firm retains all earnings to fund operations, service debt, or pursue growth initiatives rather than distributing cash to shareholders. Consequently, the overall growth and income profile is characterized by revenue expansion without shareholder income distribution, relying on retained earnings and potential capital market activity to drive future development.